201 related articles for article (PubMed ID: 25169592)
1. Treatment of coronary bifurcation lesions with the Absorb bioresorbable vascular scaffold in combination with the Tryton dedicated coronary bifurcation stent: evaluation using two- and three-dimensional optical coherence tomography.
Grundeken MJ; Hassell ME; Kraak RP; de Bruin DM; Koch KT; Henriques JP; van Leeuwen TG; Tijssen JG; Piek JJ; de Winter RJ; Wykrzykowska JJ
EuroIntervention; 2015 Dec; 11(8):877-84. PubMed ID: 25169592
[TBL] [Abstract][Full Text] [Related]
2. Anatomical and functional assessment of Tryton bifurcation stent before and after final kissing balloon dilatation: Evaluations by three-dimensional coronary angiography, optical coherence tomography imaging and fractional flow reserve.
Pyxaras SA; Toth GG; Di Gioia G; Ughi GJ; Tu S; Rusinaru D; Adriaenssens T; Reiber JHC; Leon MB; Bax JJ; Wijns W
Catheter Cardiovasc Interv; 2017 Jul; 90(1):E1-E10. PubMed ID: 27567002
[TBL] [Abstract][Full Text] [Related]
3. Randomized Comparison Between Everolimus-Eluting Bioresorbable Scaffold and Metallic Stent: Multimodality Imaging Through 3 Years.
Onuma Y; Honda Y; Asano T; Shiomi H; Kozuma K; Ozaki Y; Namiki A; Yasuda S; Ueno T; Ando K; Furuya J; Hanaoka KI; Tanabe K; Okada K; Kitahara H; Ono M; Kusano H; Rapoza R; Simonton C; Popma JJ; Stone GW; Fitzgerald PJ; Serruys PW; Kimura T
JACC Cardiovasc Interv; 2020 Jan; 13(1):116-127. PubMed ID: 31918929
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial comparing two stent sizing strategies in coronary bifurcation treatment with bioresorbable vascular scaffolds - The Absorb Bifurcation Coronary (ABC) trial.
Rampat R; Mayo T; Hildick-Smith D; Cockburn J
Cardiovasc Revasc Med; 2019 Jan; 20(1):43-49. PubMed ID: 30170828
[TBL] [Abstract][Full Text] [Related]
5. Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data.
Bourantas CV; Serruys PW; Nakatani S; Zhang YJ; Farooq V; Diletti R; Ligthart J; Sheehy A; van Geuns RJ; McClean D; Chevalier B; Windecker S; Koolen J; Ormiston J; Whitbourn R; Rapoza R; Veldhof S; Onuma Y; Garcia-Garcia HM
EuroIntervention; 2015 Nov; 11(7):746-56. PubMed ID: 25308301
[TBL] [Abstract][Full Text] [Related]
6. Serial 5-Year Evaluation of Side Branches Jailed by Bioresorbable Vascular Scaffolds Using 3-Dimensional Optical Coherence Tomography: Insights From the ABSORB Cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Onuma Y; Grundeken MJ; Nakatani S; Asano T; Sotomi Y; Foin N; Ng J; Okamura T; Wykrzykowska JJ; de Winter RJ; van Geuns RJ; Koolen J; Christiansen EH; Whitbourn R; McClean D; Smits P; Windecker S; Ormiston JA; Serruys PW
Circ Cardiovasc Interv; 2017 Sep; 10(9):. PubMed ID: 28893770
[TBL] [Abstract][Full Text] [Related]
7. Serial intravascular ultrasound analysis of complex bifurcation coronary lesions treated with the Tryton Bifurcation Stent in conjunction with an everolimus-eluting stent: IUVANT (Intravascular Ultrasound Evaluation of Tryton Stent) study.
Bartorelli AL; Trabattoni D; Almonacid A; Fabbiocchi F; Montorsi P; Galli S; Grancini L; Ravagnani P; Mintz GS; Kaplan AV; Popma JJ; Maehara A
Catheter Cardiovasc Interv; 2015 Mar; 85(4):544-53. PubMed ID: 25115944
[TBL] [Abstract][Full Text] [Related]
8. ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance.
Mattesini A; Secco GG; Dall'Ara G; Ghione M; Rama-Merchan JC; Lupi A; Viceconte N; Lindsay AC; De Silva R; Foin N; Naganuma T; Valente S; Colombo A; Di Mario C
JACC Cardiovasc Interv; 2014 Jul; 7(7):741-50. PubMed ID: 25060016
[TBL] [Abstract][Full Text] [Related]
9. Segmental comparison between a dedicated bifurcation stent and balloon angioplasty using intravascular ultrasound and three-dimensional quantitative coronary angiography: A subgroup analysis of the Tryton IDE randomized trial.
Grundeken MJ; Garcia-Garcia HM; Kumsars I; Lesiak M; Kayaert P; Dens J; Stella PR; de Winter RJ; Laak LL; Généreux P; Kaplan AV; Leon MB; Wykrzykowska JJ; Onuma Y; Serruys PW
Catheter Cardiovasc Interv; 2017 Feb; 89(2):E53-E63. PubMed ID: 27083384
[TBL] [Abstract][Full Text] [Related]
10. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
[TBL] [Abstract][Full Text] [Related]
11. Side branch healing patterns of the Tryton dedicated bifurcation stent: a 1-year optical coherence tomography follow-up study.
Grundeken MJ; Garcia-Garcia HM; Kraak RP; Woudstra P; de Bruin DM; van Leeuwen TG; Koch KT; Tijssen JG; de Winter RJ; Wykrzykowska JJ
Int J Cardiovasc Imaging; 2014 Dec; 30(8):1445-56. PubMed ID: 25062748
[TBL] [Abstract][Full Text] [Related]
12. Optical Coherence Tomography for Coronary Bioresorbable Vascular Scaffold Implantation: A Randomized Controlled Trial.
Lee SY; Kang DY; Hong SJ; Ahn JM; Ahn CM; Park DW; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Park SJ; Hong MK
Circ Cardiovasc Interv; 2020 Jan; 13(1):e008383. PubMed ID: 32525410
[TBL] [Abstract][Full Text] [Related]
13. Healing responses after bifurcation stenting with the dedicated TRYTON Side-Branch Stent™ in combination with XIENCE-V™ stents: a clinical, angiography, fractional flow reserve, and optical coherence tomography study: the PYTON (Prospective evaluation of the TRYTON Side-Branch Stent™ with an additional XIENCE-v™ everolimus-eluting stent in coronary bifurcation lesions) study.
Dubois C; Adriaenssens T; Ughi G; Wiyono S; Bennett J; Coosemans M; Ferdinande B; Sinnaeve P; D'hooge J; Desmet W
Catheter Cardiovasc Interv; 2013 Feb; 81(3):E155-64. PubMed ID: 22745031
[TBL] [Abstract][Full Text] [Related]
14. Coronary artery perforation after bioresorbable scaffold implantation treated with a new generation covered stent-OCT insights.
Chen D; Gadeley R; Wang A; Jepson N
BMC Cardiovasc Disord; 2022 Feb; 22(1):66. PubMed ID: 35196989
[TBL] [Abstract][Full Text] [Related]
15. Complex bifurcation lesions: Randomized comparison of a fully bioresorbable modified t stenting strategy versus bifurcation reconstruction with a dedicated self-expanding stent in combination with bioresorbable scaffolds, an OCT study: Rationale and design of the COBRA II trial.
Bennett J; Adriaenssens T; Desmet W; Dubois C
Catheter Cardiovasc Interv; 2016 Nov; 88(6):843-853. PubMed ID: 27184586
[TBL] [Abstract][Full Text] [Related]
16. Angiographic and Midterm Outcomes of Bioresorbable Vascular Scaffold for Coronary Bifurcation Lesions.
Paradies V; Vlachojannis GJ; Royaards KJ; Wassing J; van der Ent M; Smits PC
Am J Cardiol; 2018 Dec; 122(12):2035-2042. PubMed ID: 30360886
[TBL] [Abstract][Full Text] [Related]
17. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.
Onuma Y; Dudek D; Thuesen L; Webster M; Nieman K; Garcia-Garcia HM; Ormiston JA; Serruys PW
JACC Cardiovasc Interv; 2013 Oct; 6(10):999-1009. PubMed ID: 24156961
[TBL] [Abstract][Full Text] [Related]
18. The relationship of pre-procedural Dmax based sizing to lesion level outcomes in Absorb BVS and Xience EES treated patients in the AIDA trial.
Tijssen RYG; Kerkmeijer LSM; Katagiri Y; Kraak RP; Takahashi K; Kogame N; Chichareon P; Modolo R; Asano T; Nassif M; Kalkman DN; Sotomi Y; Collet C; Hofma SH; van der Schaaf RJ; Arkenbout EK; Weevers APJD; Beijk MAM; Piek JJ; Tijssen JGP; Henriques JP; de Winter RJ; Onuma Y; Serruys PW; Wykrzykowska JJ
Int J Cardiovasc Imaging; 2019 Jul; 35(7):1189-1198. PubMed ID: 30911857
[TBL] [Abstract][Full Text] [Related]
19. In-scaffold restenosis in a previous left main bifurcation lesion treated with bioresorbable scaffold v-stenting.
Miyazaki T; Panoulas VF; Sato K; Kawamoto H; Naganuma T; Latib A; Colombo A
JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):e7-e10. PubMed ID: 25499306
[No Abstract] [Full Text] [Related]
20. Six-month clinical follow-up of the Tryton side branch stent for the treatment of bifurcation lesions: a two center registry analysis.
Magro M; Wykrzykowska J; Serruys PW; Simsek C; Nauta S; Lesiak M; Stanislawska K; Onuma Y; Regar E; van Domburg RT; Grajek S; Geuns RJ
Catheter Cardiovasc Interv; 2011 May; 77(6):798-806. PubMed ID: 20824767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
